1. Home
  2. GRCE vs DFLI Comparison

GRCE vs DFLI Comparison

Compare GRCE & DFLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GRCE
  • DFLI
  • Stock Information
  • Founded
  • GRCE 2002
  • DFLI 2020
  • Country
  • GRCE United States
  • DFLI United States
  • Employees
  • GRCE N/A
  • DFLI N/A
  • Industry
  • GRCE
  • DFLI Electronic Components
  • Sector
  • GRCE
  • DFLI Technology
  • Exchange
  • GRCE NYSE
  • DFLI Nasdaq
  • Market Cap
  • GRCE 30.9M
  • DFLI 36.1M
  • IPO Year
  • GRCE N/A
  • DFLI N/A
  • Fundamental
  • Price
  • GRCE $3.34
  • DFLI $3.46
  • Analyst Decision
  • GRCE
  • DFLI Strong Buy
  • Analyst Count
  • GRCE 0
  • DFLI 5
  • Target Price
  • GRCE N/A
  • DFLI $1.74
  • AVG Volume (30 Days)
  • GRCE 29.7K
  • DFLI 91.3K
  • Earning Date
  • GRCE 11-13-2024
  • DFLI 11-14-2024
  • Dividend Yield
  • GRCE N/A
  • DFLI N/A
  • EPS Growth
  • GRCE N/A
  • DFLI N/A
  • EPS
  • GRCE N/A
  • DFLI N/A
  • Revenue
  • GRCE N/A
  • DFLI $48,871,000.00
  • Revenue This Year
  • GRCE N/A
  • DFLI N/A
  • Revenue Next Year
  • GRCE N/A
  • DFLI $50.98
  • P/E Ratio
  • GRCE N/A
  • DFLI N/A
  • Revenue Growth
  • GRCE N/A
  • DFLI N/A
  • 52 Week Low
  • GRCE $1.98
  • DFLI $2.96
  • 52 Week High
  • GRCE $3.60
  • DFLI $13.14
  • Technical
  • Relative Strength Index (RSI)
  • GRCE N/A
  • DFLI 37.27
  • Support Level
  • GRCE N/A
  • DFLI $2.96
  • Resistance Level
  • GRCE N/A
  • DFLI $4.39
  • Average True Range (ATR)
  • GRCE 0.00
  • DFLI 0.54
  • MACD
  • GRCE 0.00
  • DFLI -0.08
  • Stochastic Oscillator
  • GRCE 0.00
  • DFLI 24.75

About GRCE GRACE THERAPEUTICS INC

Grace Therapeutics Inc is a late-stage specialty pharma company with drug delivery technologies and drug candidates addressing rare and orphan diseases. The company's lead drug candidate, GTx-104, is a novel injectable formulation of nimodipine for the treatment of a rare disease, aneurysmal subarachnoid hemorrhage.

About DFLI Dragonfly Energy Holdings Corp. (NV)

Dragonfly Energy Holdings Corp is a manufacturer of non-toxic deep cycle lithium-ion batteries that are designed to displace lead acid batteries in a number of different storage applications and end markets including RV, marine vessel, and solar and off-grid industries, with disruptive solid-state cell technology currently under development. The company's deep cycle lithium iron phosphate ("LFP") batteries provide numerous advantages compared to incumbent products, such as lead-acid batteries. LFP batteries are non-toxic and environmentally friendly, do not rely on scarce or controversial metals, and are a highly cost-effective storage solution.

Share on Social Networks: